One patient with recurrenthepatitis B developed chronic severe hepatitis B despite treatment.
2
The severity of recurrenthepatitis C virus (HCV) is likely related to several factors.
3
Methods: Twenty-nine cases of recurrenthepatitis C and 26 cases of ACR were included in this study.
4
One patient died of recurrenthepatitis C and graft failure without evidence of tuberculous infection at death.
5
Conclusions: Improving the outcome of recurrenthepatitis C may be achieved by reducing overall immunosuppression and avoiding abrupt variations in immunosuppression.
6
This study aimed to assess the safety and efficacy of interferon alfa-2b plus ribavirin for recurrenthepatitis C following liver transplantation.
7
The treatment for recurrenthepatitis B after liver transplantation includes increased dosage of lamivudine, application of famciclovir, and other liver protection measures.
8
Conclusions: Hepatitis B virus reinfection or recurrenthepatitis B following liver transplantation occurs mostly 6-12 months after operation.
9
Recurrenthepatitis C after liver transplantation remains a significant cause of graft loss and retransplantation.
10
Background and aims: Recurrenthepatitis C after liver transplantation (LT) is associated with rapid fibrosis progression.
11
Recurrenthepatitis B virus (HBV) infection of the liver graft is characterized by a severe outcome and high level of HBV replication.